Aptose Biosciences Inc. (TSE:APS – Get Free Report) (NASDAQ:APTO) was up 19.6% during mid-day trading on Wednesday . The company traded as high as C$0.33 and last traded at C$0.31. Approximately 20,804 shares were traded during trading, a decline of 16% from the average daily volume of 24,911 shares. The stock had previously closed at C$0.26.
Aptose Biosciences Stock Up 35.3 %
The stock has a 50 day moving average price of C$0.30 and a 200 day moving average price of C$0.46. The company has a market cap of C$6.25 million, a P/E ratio of -0.06 and a beta of 1.36. The company has a debt-to-equity ratio of 670.80, a quick ratio of 5.41 and a current ratio of 0.80.
About Aptose Biosciences
Aptose Biosciences Inc, a clinical-stage biotechnology company, discovers and develops personalized therapies addressing unmet medical needs in oncology in Canada. Its lead clinical program is APTO-253, which is a Phase I clinical trial for the treatment of patients with relapsed or refractory hematologic malignancies.
Featured Stories
- Five stocks we like better than Aptose Biosciences
- The Significance of Brokerage Rankings in Stock Selection
- Inflation Persists, But So Do Stock Opportunities: Rally On
- Stock Trading Terms – Stock Terms Every Investor Needs to Know
- Energy Transfer Fuels the Cloud: A Natural Gas Power Play
- 3 Grocery Stocks That Can Help Take a Bite Out of Inflation
- Shopify Confirms Stock Uptrend, New Highs in Sight
Receive News & Ratings for Aptose Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aptose Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.
